The objectives of the study were to use a novel immunofluorescence imaging method to quantify the level of pAktser473 in tumor tissue sections, to determine whether inhibition of the PI3K signaling pathway caused anti-tumor effects in the basal-like xenograft model, and to identify metabolic biomarkers associated with response to treatment. The gene discussed is PIK3CA; the disease is neoplasm.